Research Notes on Bayer Discontinues Trasylol
The antibleeding drug trasylol has been recalled. Bayer said it would halt all sales until results of a trial were finalized. The results were released on Wednesday and they confirmed that there is more than a 50% increase in death risk among patients taking trasylol.
Top Resources on Bayer Discontinues Trasylol
- Bloomberg: Bayer Will Begin Pulling Remaining Stock of Trasylol (May 14, 2008)
- Reuters: Bayer pulls Trasylol supplies after study (May 14, 2008)
- Associated Press: Study likely spells end for anti-bleeding drug (May 15, 2008)
- Chronicle Herald: Anti-bleeding drug raises death risk (May 15, 2008)
- Wall Street Journal: Bayer Antibleeding Drug Takes Hit (May 15, 2008)
Sponsored Links
User Recommended Links for Bayer Discontinues Trasylol
Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.
About this WisdomCard
- Contributor: Amy Sandhu
- Reviewer: Chris Miller
- Supervised by: The OrganizedWisdom Physician Review Team
- Last update: Sep. 10, 2008
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic. In addition to filtering out spam and bad links, WisdomCards highlight tips and warnings, such as:
- Guide Favorite
- Guide Warning
- Scroll down to reach relevant content
- Video
- In Memoriam
Help improve this WisdomCard by suggesting great links.
RSS: 
